Airbus and Boeing watch out - one of the world's largest aircraft owners says passenger planes could see their wings clipped by the rapid spread of flying taxi startups.
Commercial air travel already faces competition from high-speed trains in parts of the world. But the head of Irish aircraft leasing firm Avolon said competition would shift skywards as it invested up to $2 billion in aerial shuttles.
Avolon is among the launch customers for up to 1,000 electric Vertical Take-Off and Landing (eVOTL) aircraft being developed by Britain's Vertical Aerospace, which plans to go public through a merger with a blank-check firm.
German air shuttle startup Lilium said in March it would float on the US stock market via a similar process.
The deals reflect growing interest in battery-powered aircraft that can take off and land vertically, offering a new way for travellers to beat traffic and hop between cities.
Vertical's VA-X4 has a range of 120 miles but that could be extended further, Avolon Chief Executive Domhnal Slattery said on late Thursday.
"The challenge for incumbent (planemakers) is if the range can extend to 400-500 miles, what is the implication for traditional narrowbodies?" he said in a Reuters interview.
Asked if the vehicles for four passengers and a pilot could take business from much larger commercial planes, Slattery said, "Eventually, yes of course. This is the inevitable future."
Planemakers have themselves invested in such projects.
Helicopter travel could also be squeezed.
"You have got to think that you have these machines that can disintermediate the legacy helicopters through just being 100 times quieter and no emissions," Slattery said.
Avolon has placed a firm order for 310 eVTOLs worth $1.25 billion and 190 options worth $750 million, Slattery said.
They will join an owned or managed fleet of 568 passenger aircraft all the way up to the 396-seat Boeing 777-300ER.
Comments are moderated and generally will be posted if they are on-topic and not abusive.
For more information, please see our Comments FAQ